Effect of Acupuncture for Diminished Ovarian Reserve: A Randomized Sham-Controlled Trial
International Journal of Women's Health · 2026-04 · Volume 18 · 1-9
DOI: 10.2147/ijwh.s580821 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Women's Health, 2026-04. Verfasst von Xiaoyan Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Objective
Acupuncture is a potential intervention for diminished ovarian reserve (DOR); however, the evidence remains limited. This single-center, randomized, sham-acupuncture controlled trial was conducted to evaluate the efficacy and safety of acupuncture in treating DOR.
Methods
A total of 120 DOR patients aged 18-40 years were randomized to receive acupuncture or sham acupuncture. The treatment lasted 12 weeks, with 20-minute sessions three times weekly, followed by a 12-week follow-up. The primary outcome was the change in antral follicle count (AFC) from baseline to week 12. Secondary outcomes included serum levels of anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), menstrual cycle length, and self-rating anxiety scale (SAS) scores.
Results
Of the participants, 108 completed the study. Both acupuncture and sham acupuncture interventions exhibited statistically significant increases in AFC at weeks 12 and 24 versus baseline. The acupuncture group had significantly higher AFC values compared to sham controls at both evaluation timepoints. At week 12, the acupuncture group showed a significantly greater increase in AFC (median [IQR], 2.00 [0 to 4.00]) compared to the sham group (0 [0 to 0.25]), with a between-group pseudo-median difference of 1.00 (95% CI, 0 to 2.00; p=0.003). By week 24, although improvements in AFC persisted, between-group differences became non-significant. Both groups demonstrated increases in AMH and decreases in FSH at weeks 12 and 24 compared to baseline, though between group comparisons revealed no statistically significant differences. There were no significant differences between groups in E2, LH, and menstrual cycle length. A statistically significant between-group difference in SAS was noted exclusively at week 24. Treatment related adverse events were mild and infrequent.
Conclusion
A 12-week of acupuncture significantly improved AFC in women with DOR compared to sham acupuncture. Further large-scale studies are warranted to confirm these findings and assess long-term outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China.
- Acupuncture and Moxibustion Hospital, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China.
ORCID-Profile: Xiaoyan Wang, Lingyu Qi
Zitieren
APA
Wang, X., Du, P., Yang, L., Li, J., Hang, T., Qi, L., Su, C., Liu, X., Li, W., Zhu, Y., Lu, G., Xu, H., & Fang, Y. (2026). Effect of Acupuncture for Diminished Ovarian Reserve: A Randomized Sham-Controlled Trial. International Journal of Women's Health, Volume 18, 1-9. https://doi.org/10.2147/ijwh.s580821
Vancouver
Wang X, Du P, Yang L, Li J, Hang T, Qi L, et al. Effect of Acupuncture for Diminished Ovarian Reserve: A Randomized Sham-Controlled Trial. International Journal of Women's Health. 2026;Volume 18:1-9. doi:10.2147/ijwh.s580821
BibTeX
@article{Wang2026,
author = {Wang, Xiaoyan and Du, Pengfei and Yang, Li and Li, Jiashan and Hang, Tian and Qi, Lingyu and Su, Chenchen and Liu, Xin and Li, Weixin and Zhu, Yaoyao and Lu, Ge and Xu, Huanfang and Fang, Yigong},
title = {Effect of Acupuncture for Diminished Ovarian Reserve: A Randomized Sham-Controlled Trial},
journal = {International Journal of Women's Health},
year = {2026},
volume = {Volume 18},
pages = {1--9},
doi = {10.2147/ijwh.s580821}
}
EUVIMED